Roles & Responsibilities:
Coordinates initial market, technology, and funding assessments. Responsible for prioritization of technology objectives and composition of technology product profiles. Will lead all aspects of technology transfer and commercialization operations to ensure the sustainability of MTEC through revenue streams that include royalties from patents generated, venture and/or private equity investments, commercial test agreements and other income sources.
Lauren Palestrini, Ph.D., is the Director of Research at MTEC, where she serves as the lead technology officer within the medical product development activities, oversees the development of technology solutions that will meet industry commercialization targets, conducts initial technology assessments, and maintains adequate coverage of military clinical needs. Dr. Palestrini is also working on generating external funding streams through fundraising. Dr. Palestrini earned a Bachelor of Science Degree in Chemical Engineering from Cornell University, and a Doctoral Degree in Biomedical Engineering from Stony Brook University. Her graduate work focused on the development of a biodegradable, electrospun fiber mat for the topical delivery of a novel fibronectin-derived peptide for the limitation of burn injury progression. Until recently, she served as the Director of Research at the New Jersey Center for Biomaterials at Rutgers University where she managed a cross-disciplinary set of research projects in support of the Department of Defense-funded Armed Forces Institute of Regenerative Medicine (AFIRM) cooperative agreement within regenerative medicine. In addition, her prior experience includes process development at Regeneron Pharmaceuticals, research and development at Johnson & Johnson Consumer Products, and human resources at Deutsche Bank.